Prediction tool for chemotherapy toxicity in older adults with cancer
A predictive model for chemotherapy toxicity in older adults with cancer that consists of 11 questions (c-indices: 0.65-0.72).
Research authors: Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, Lichtman SM, Gajra A, Bhatia S, Katheria V, Klapper S, Hansen K, Ramani R, Lachs M, Wong FL, Tew WP
Version: 1.26
  • Public
  • Oncology
  • {{ modelType }}
  • Details
  • Validate model
  • Save input
  • Load input

{{section.title}}

Calculate the result

Set more parameters to perform the calculation

Chemotoxicity risk score is: points (see result interpretation below)

{{ resultSubheader }}
{{ chart.title }}
Result interval {{ additionalResult.min }} to {{ additionalResult.max }}

Conditional information

How this model should be used: 
This risk stratification schema establishes the risk of chemotherapy toxicity in older adults.

Overall model performance: 
Upon internal validation in the original study population (N=500), discriminative power of the model was reasonable to good with an area under the ROC curve (c-index) of 0.72 (95% CI: 0.68 to 0.77).1 In an external validation (N=250) performed by the same research group, a c-index of 0.65 (95% CI: 0.58 to 0.71) was reported.2

Model performance versus KPS:
Physician-rated Karnofsky Performance Score (KPS) was not predictive of chemotherapy toxicity (Figure 1)in either the development cohort (P=0.19) or the validation cohort (P=0.25), with correponding c-indices of 0.54 and 0.53, respectively. 

Sources:
1 Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29(25):3457-65.
2 Hurria A, Mohile S, Gajra A, et al. Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer. J Clin Oncol. pii: JCO654327.

{{ file.classification }}
PRO
Note
Notes are only visible in the result download and will not be saved by Evidencio

This model is provided for educational, training and information purposes. It must not be used to support medical decision making, or to provide medical or diagnostic services. Read our full disclaimer.

Underlying models Part of
Comments
Comment
Please enter a comment
Comments are visible to anyone

Model feedback

No feedback yet 1 Comment {{ model.comments.length }} Comments
On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
{{ comment.content }}
logo

Please sign in to enable Evidencio print features

In order to use the Evidencio print features, you need to be logged in.
If you don't have an Evidencio Community Account you can create your free personal account at:

https://www.evidencio.com/registration

Printed results - Examples {{ new Date().toLocaleString() }}

Evidencio Community Account Benefits

With an Evidencio Community account you can:

  • Create and publish your own prediction models.
  • Share your prediction models with your colleagues, research group, organization or the world.
  • Review and provide feedback on models that have been shared with you.
  • Validate your models and validate models from other users.
  • Find models based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction models and their data.
  • Use patient specific protocols and guidelines based on sequential models and decision trees.
  • Stay up-to-date with new models in your field as they are published.
  • Create your own lists of favorite models and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction models.

Disclaimer: Calculations alone should never dictate patient care, and are no substitute for professional judgement.
Terms & Conditions | Privacy Policy | Disclaimer | Contact | Refuse cookies |
Evidencio v3.30 © 2015 - 2024 Evidencio. All Rights Reserved